EquityZen Growth Technology Fund LLC - Series 2192
Raised
$353K
Investors
27
Min Invest
$10,038
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2192 is a Delaware pooled investment fund filed by EquityZen Advisors LLC that raised $353K from 27 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. This series is part of the EquityZen platform, which operates over 1,889 special purpose vehicles enabling pre-IPO equity investments.
This pre-IPO SPV follows the standard EquityZen structure: a 506(b) private placement combined with 3(c)(1) investment company exemption, a retail-accessible $10K minimum, and concentrated capital deployment. The $13K average investor commitment and sub-$500K total raise are typical for single-company access vehicles in the platform model.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.